Skip to main content
. Author manuscript; available in PMC: 2016 Jul 12.
Published in final edited form as: J Heart Lung Transplant. 2014 Dec 23;34(7):873–882. doi: 10.1016/j.healun.2014.12.009

Table 2.

Comparison of HTx Candidates Who Did or Did Not Have Liver Biopsy

Biopsy
(n = 68)
No biopsy
(n = 200)
p-value
Total bilirubin (mg/dl) 2.53 ± 5.0 1.7 ± 2.1 0.19
Creatinine (mg/dl) 1.74 ± 1.3 1.49 ± 0.8 0.14
Albumin (mg/dl) 3.6 ± 0.7 3.78 ± 0.6 0.04
MELD-XI 12.7 ± 3.3 13.2 ± 5.2 0.33
Fibrosis or cirrhosis on
  abdominal sonogram (%)
76.5 21.5 < 0.001
Serologic evidence of
  hepatitis B or C (%)
32.4 13.5 < 0.001

MELD-XI, Model of End-stage Liver Dysfunction eXcluding International normalized ratio.